Public Policy Page Contents
- PSAB Documents (Statements, Reports, Testimony and Monthly Newsletters)
- Research and Development Funding for FY 2016
- Clinical Microbiology Resources
- Public and Scientific Affairs Board Information
- Federal and State Government Links
- Congressional Science Fellowship
Check Here for Critical Public Policy Information
- Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
- Committee on the Status of Women in Microbiology
- Committee on Microbiological Issues Impacting Minorities
Public and Scientific Affairs Board (PSAB)
Underlying the ASM's dedication to the advancement of scientific knowledge is its commitment that science serve the public interest. To address scientific matters affecting the public interest, the ASM created the Public and Scientific Affairs Board (PSAB) in 1979. The PSAB monitors legislation and regulation and develops positions for the Society on public policy issues. The PSAB encourages the adoption of sound policies affecting science and technology and the discipline of microbiology. The PSAB responds to policy makers who may request or require an understanding of research and technology in microbiology. It also communicates microbiological issues to the public.
What's New in Public Policy?
The ASM and and the Association of Public Health Laboratories jointly authored recommendations on the upcoming edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), which include the need for more clinical and public health representation in the document.
The ASM sent a letter to all members of the House of Representatives regarding DOE Provisions in House Amendment to S. 2012, the Energy Policy Modernization Act of 2016.
ASM and PASCV have prepared a joint guidance document to update and assist clinical laboratory personnel in testing for Zika virus, based on patient risk.
The May issue of the e-Public Policy Update has been published by the ASM Office of Public Affairs.
The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.
ASM volunteer leaders have on been Capitol Hill advocating for funding for the microbial sciences and their messages have accelerated congressional action on funding to address the Zika threat.
May 11, 2016 – ASM Comments on Department of Labor Employee Exemptions Definitions Impact on Research
The ASM sent a letter to Howard A. Shelanski, Ph.D., Administrator, Office of Information and Regulatory Affairs, Office of Management and Budget regarding the impact of the Department of Labor’s “Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees” on research.
The May issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities.
A key role of a scientific association is to make the voices of its many individual members heard as a unified whole. Speaking on behalf of its 47,000 members worldwide, ASM has acted quickly to make the case to policy makers that we must take immediate and aggressive action against...
The ASM sent a bulk e-mail to members soliciting input for the Biosafety in Microbiological and Biomedical Laboratories (BMBL) Revision.